At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
New Numbers on America's Most Common Cancer
The sun's rays may give you that healthy glow — but below the surface, there may be serious health risks.
Some Skin Cancers Saw Spike
As awareness about the dangers of sun exposure and skin cancer rises, the hope is that skin cancer rates will decrease. New evidence, however, suggests that rates may not be on the decline.
Melanoma on Downswing in Kids
Parents, you can breathe a sigh of relief — the sunscreen must be working. Melanoma, an aggressive form of skin cancer, appears to be decreasing in kids.
Bristol-Myers Squibb and Lilly Colaborate to Evaluate Cancer Drug
NEW YORK & INDIANAPOLIS--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) and Eli Lilly and Company (NYSE:LLY) announced today a clinical trial collaboration to evaluate the safety, tolerability and preliminary efficacy of Bristol-Myers Squibb's immunotherapy Opdivo (nivolumab) in combination with Lilly's galunisertib (LY2157299).
More Coffee, Less Skin Cancer
Wear sunscreen, stay inside during the hottest parts of the day and ... refill your cup of coffee? Sure enough, that fourth cup of joe has been tied to lower rates of an aggressive type of skin cancer.
Students Saving Their Hides From Indoor Tanning
That "healthy glow" you get from indoor tanning might not be so healthy — especially for people who start tanning at a young age. Fortunately, teens are less likely to tan now than they were a few years ago.
FDA Approves New Skin Cancer Rx
Bristol-Myers Squibb's new skin cancer drug has been approved by the US Food and Drug Administration (FDA).
Up in the Air, Radiation Exposure Was Higher
Pilots and cabin crew members may want to make sure sunscreen is part of their pre-flight routine.
Novogen Announces Breakthrough Discovery in the Treatment of Melanoma
Novogen Limited, Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.
Cancer Screening May Benefit Diabetes Patients
Diabetes patients may need to take extra precautions to lower their risk for cancer or catch it early.